Montana Activists Protect Access to Disease-Modifying Therapies in Montana
October 31, 2014
When the chair of the Society’s Montana Government Relations Committee, Deanna McCann, realized she had a key connection to her state’s Insurance Commissioner, she took action to address the unfair cost-sharing practices for specialty-tier medications by Montana’s insurers. Deanna and fellow activists convinced the Commissioner to investigate the state’s insurance plans’ practices. Now insurers must provide at least one plan option with pre-deductible copays for all drug tiers – meaning that consumers on select plans will pay no more than $250 each month for a disease-modifying drug. In addition, the Commissioner’s office will train Marketplace healthcare navigators to help those needing high-cost medications find these plans. What great steps toward ensuring MS treatments are affordable to all who need them! Read more about Deanna’s success on the Billings Gazette.